Mitoxantrone HCl 2mg/mL Injection for Dogs and Cats.

Antineoplastic for dogs and cats

Pronunciation – (mye-toe-zan-trone)

Vial Size: 10mL

Mitoxantrone HCl 2mg/mL Injection for Dogs and Cats can be useful in the treatment of  several neoplastic diseases in dogs and cats, including lymphosarcoma mammary adenocarcinoma, squamous cell carcinoma, renal adenocarcinoma, fibroid sarcoma, thyroid or transitional cell carcinomas and hemangiopericytoma.

Adverse Effects – Vomiting, diarrhea, anorexia and bone narrow depression. Tiredness may occur. Seizures may develop in cats taking this medication.

Other names: Novantrone®

For Intravenous Infusion

Each mL contains mitoxantrone hydrochloride USP equivalent to 2mg of mitoxantrone free base.

Inactive Ingredients: sodium chloride 0.800% w/v sodium acetate anhydrous 0.005% w/v glacial acetic acid 0.046% w/v water for injection.

Usual Dosage: See prescribing information for dosage and administration.

Storage: Store at 20º to 25°C (68º to 77ºF) (See USP Controlled Room Temperature).

After penetration of the stopper, store vials no longer than 7 days between 15º to 25ºC (59º to 77ºF) or 14 days under refrigeration.

DO NOT FREEZE.

CONTAINS NO PRESERVATIVE.

Specialty Veterinary Pharmacy does not make any claims of efficacy for this medication. These medications is not an FDA approved for cats and dogs.